[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-detail-18376":3,"doc-seo-18376":27},{"code":4,"msg":5,"data":6},0,"success",{"doc_id":7,"user_id":8,"nickname":9,"user_avatar":10,"doc_module":4,"category_id":11,"category_name":12,"doc_title":13,"doc_description":14,"file_id":15,"file_url":16,"file_type":17,"file_size":18,"view_count":19,"is_deleted":4,"is_public":20,"is_downloadable":20,"audit_status":20,"page_count":21,"language":22,"language_code":23,"table_of_contents":24,"faqs":24,"seo_title":13,"seo_description":14,"update_tm":25,"read_time":26},18376,7971461740886,"Theodore","https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2",8,"Research & Report","Optimizing Neuroprotective Nano-structured Lipid Carriers for Transdermal Delivery through Artificial Neural Network","Optimizing nanostructured lipid carrier (NLC) formulations for transdermal delivery of donepezil HCl and memantine HCl to support neuroprotective treatment for dementia associated with Alzheimer’s disease. NLCs were produced by high-speed homogenization and ultrasonication, then optimized using Box Behnken Design and artificial neural network modeling. Optimized particles showed nanoscale size, high entrapment efficiency, negative zeta potential, supportive CryoSEM structure, and prolonged permeation and release profiles.","cbCaidHPoz86IgCJ","https://ap.wps.com/l/cbCaidHPoz86IgCJ","pdf",3685283,16,1,15,"English","en","",1776718895,38,{"code":4,"msg":28,"data":29},"ok",{"site_id":30,"language":23,"slug":31,"title":13,"keywords":24,"description":14,"schema_data":32,"social_meta":67,"head_meta":70,"extra_data":72,"updated_unix":25},105,"optimizing-neuroprotective-nano-structured-lipid-carriers-for-transdermal-delivery-through-artificial-neural-network",{"@graph":33,"@context":66},[34,51],{"@type":35,"itemListElement":36},"BreadcrumbList",[37,41,45,48],{"item":38,"name":39,"@type":40,"position":20},"https://docshare.wps.com","Home","ListItem",{"item":42,"name":43,"@type":40,"position":44},"https://docshare.wps.com/document/","Document",2,{"item":46,"name":12,"@type":40,"position":47},"https://docshare.wps.com/document/research-report/",3,{"item":49,"name":13,"@type":40,"position":50},"https://docshare.wps.com/document/optimizing-neuroprotective-nano-structured-lipid-carriers-for-transdermal-delivery-through-artificial-neural-network/18376/",4,{"url":49,"name":13,"@type":52,"author":53,"headline":13,"publisher":55,"fileFormat":58,"description":14,"dateModified":59,"datePublished":60,"encodingFormat":58,"isAccessibleForFree":61,"interactionStatistic":62},"DigitalDocument",{"name":9,"@type":54},"Person",{"url":38,"name":56,"@type":57},"DocShare","Organization","application/pdf","2026-06-05","2026-04-20",true,{"@type":63,"interactionType":64,"userInteractionCount":19},"InteractionCounter",{"@type":65},"ViewAction","https://schema.org",{"og:url":68,"og:type":69,"og:title":13,"og:site_name":56,"og:description":14},"https://docshare.wps.com/document/optimizing-neuroprotective-nano-structured-lipid-carriers-for-transdermal-delivery-through-artificial-neural-network/18376","article",{"robots":71,"canonical":68},"index,follow",{"doc_id":7,"site_id":30}]